Atlas Capital Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.69K Hold
110
﹤0.01% 930
2026
Q1
$6.9K Hold
110
﹤0.01% 820
2025
Q4
$10.5K Buy
+110
New +$10.8K ﹤0.01% 755
2025
Q2
$11.8K Hold
110
﹤0.01% 762
2025
Q1
$11.1K Hold
110
﹤0.01% 791
2024
Q4
$9.82K Hold
110
﹤0.01% 782
2024
Q3
$9.22K Hold
110
﹤0.01% 736
2024
Q2
$8.47K Hold
110
﹤0.01% 746
2024
Q1
$7.53K Hold
110
﹤0.01% 739
2023
Q4
$6.36K Hold
110
﹤0.01% 779
2023
Q3
$5.81K Hold
110
﹤0.01% 756
2023
Q2
$5.95K Hold
110
﹤0.01% 775
2023
Q1
$5.5K Hold
110
﹤0.01% 791
2022
Q4
$5.09K Hold
110
﹤0.01% 786
2022
Q3
$4.26K Sell
110
-700
-86% -$28.1K ﹤0.01% 784
2022
Q2
$30.2K Hold
810
0.01% 627
2022
Q1
$35.9K Hold
810
0.01% 579
2021
Q4
$34.4K Sell
810
-237
-23% -$9.96K 0.01% 578
2021
Q3
$45.4K Sell
1,047
-4,826
-82% -$214K 0.01% 530
2021
Q2
$251K Buy
5,873
+5,173
+739% +$218K 0.04% 324
2021
Q1
$27.1K Buy
+700
New +$26.5K 0.01% 558
2019
Q1
Sell
-548
Closed -$19.4K 566
2018
Q4
$19.4K Buy
+548
New +$19.9K 0.01% 468

Other funds holding BSX

Atlas Capital Advisors's BSX Position: Q2 2026 in Review

Atlas Capital Advisors held its Boston Scientific (BSX) position steady in Q2 2026 at 110 shares worth $4.69K. The position accounts for ﹤0.01% of the portfolio, ranked #930.

Atlas Capital Advisors first reported a position in BSX in Q4 2018 and has held it in 22 quarters since. The position peaked at $251K in Q2 2021. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Atlas Capital Advisors held 110 shares of Boston Scientific worth $4.69K as of Q2 2026.
  • Atlas Capital Advisors left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Atlas Capital Advisors's portfolio in Q2 2026, its #930 holding.
  • Atlas Capital Advisors first reported a position in Boston Scientific in Q4 2018 and has held it in 22 quarters since.
  • Atlas Capital Advisors's Boston Scientific position peaked at $251K in Q2 2021.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Atlas Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.